Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.408
+0.001 (0.27%)
At close: Jan 21, 2025, 4:00 PM
0.385
-0.023 (-5.64%)
After-hours: Jan 21, 2025, 7:25 PM EST
Invivyd Employees
As of December 31, 2023, Invivyd had 95 total employees, including 94 full-time and 1 part-time employees. The number of employees increased by 9 or 10.47% compared to the previous year.
Employees
95
Change (1Y)
9
Growth (1Y)
10.47%
Revenue / Employee
$121,726
Profits / Employee
-$2,369,853
Market Cap
48.74M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 95 | 9 | 10.47% |
| Dec 31, 2022 | 86 | -17 | -16.50% |
| Dec 31, 2021 | 103 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IVVD News
- 11 days ago - Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC - GlobeNewsWire
- 2 months ago - Invivyd, Inc. (IVVD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Invivyd Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Invivyd Announces New England Journal of Medicine Publishes Letter to the Editor Highlighting Immunobridging Pathway Leading to PEMGARDA™ (pemivibart) Emergency Use Authorization; Comments on Adjacent Third-Party Letter to the Editor - GlobeNewsWire
- 2 months ago - Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively - GlobeNewsWire
- 2 months ago - Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024 - GlobeNewsWire
- 3 months ago - Invivyd Reports Preliminary Third Quarter 2024 Results, Withdraws Prior Financial Guidance, and Targets Near-Term Profitability - GlobeNewsWire